Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of radiation dermatitis in breast cancer
IRCT20250606066086N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in breast cancer and radiodermatitis, sponsored by Shiraz University of Medical Sciences. Started Dec 2025; status: completed.
02
Drugs
metformin
03
Conditions
breast cancerradiodermatitis
Beyond the preview
Go deeper on IRCT20250606066086N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250606066086N1.